The U.S. Self-Care Marketing Awards recognize the strategic innovation and marketing expertise of our member companies in both the over-the-counter (OTC) medicine and dietary supplement industries.
Under a voluntary program which began in November 2007, manufacturers of OTC oral pediatric cough and cold medicines should take the following steps in the labeling, packaging, and promotion of these medicines.
Lawmakers should support the centralized progress made on ingredient evaluation, labeling, and packaging protections by specialized national children’s health agencies instead of allowing jurisdiction confusion that ultimately hinders healthcare advancement for all ages.
The advertising of nonprescription, over-the-counter medicines helps acquaint the public with these products and must be truthful, not misleading, and must meet high standards reflecting the nature of the product advertised.
Acetaminophen is a safe OTC analgesic that's widely used by adults and children when following recommended dosage guidelines. Lawmakers should oppose restrictions to access for either age group, as drug regulatory entities already actively monitor research and update consumer protections.
This white paper provides guidance for the evaluation and reporting of impurities in OTC monograph drug products formulated as topicals and topical rinses. This document serves as CHPA's member company consensus on this complex issue.
